May 18, 2017 / 8:12 PM / 3 months ago

BRIEF-Egalet announces results of ARYMO ER harm reduction modeling analysis

May 18 (Reuters) - Egalet Corp

* Egalet announces results of ARYMO ER harm reduction modeling analysis

* Results suggest replacement of non-abuse-deterrent, extended-release morphine with ARYMO ER could lead to reductions in opioid abuse-related events Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below